2',2'-DIFLUORO-2'-DEOXYURIDINE
-
2',2'-DIFLUORO-2'-DEOXYURIDINE
structure -
-
CAS No:
114248-23-6
-
Formula:
C9H10F2N2O5
-
Chemical Name:
2',2'-DIFLUORO-2'-DEOXYURIDINE
-
Synonyms:
2',2'-DIFLUORO-2'-DEOXYURIDINE;2Deoxy-22difluorouridine;2'-Deoxy-2',2'-difluoro-D-uridine;2',2'-Difluorodeoxyuridine;2'-Deoxy-2',2'-difluorouridine ,97%;Uridine,2'-deoxy-2',2'-difluoro-;Gemcitabine impurity C;1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
- Categories:
-
CAS No:
Safety Information
P201, P202, P260, P264, P270, P273, P280, P281, P301+P312, P302+P352, P305+P351+P338, P308+P313, P312, P314, P321, P322, P330, P332+P313, P337+P313, P362, P363, P391, P405, P501
H302
|Danger|H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P260, P264, P270, P273, P280, P281, P301+P312, P302+P352, P305+P351+P338, P308+P313, P312, P314, P321, P322, P330, P332+P313, P337+P313, P362, P363, P391, P405, and P501|Aggregated GHS information provided by 2 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
2',2'-DIFLUORO-2'-DEOXYURIDINE Use and Manufacturing
formula 11(5 g, 16.7 mmol, 1.0 eq.) Was dissolved in a 2N aqueous acetic acid solution (350 ml) Sodium nitrite (16.7 g, 14.5 eq.) Was added slowly and left at room temperature for 48 hours. 2N The mixture was adjusted to pH 6-7 with aqueous sodium hydroxide solution and then concentrated under reduced pressure. Decompression concentration After the addition of methanol / ethyl acetate (1: 5, 360 ml), the insoluble salts were removed. This process The salt was removed repeatedly several times to concentrate under reduced pressure to obtain 4.22 g of a light brown transparent oil of formula (7) in 95percent yield.Compound 68-3 was dissolved in NH3/MeOH (600 mL) and stirred overnight. The solvent was concentratedto give the residue, which was purified by silica gel column chromatography (5percent MeOH in DCM) to give68-4 (12 g, 99percent) as a white solidCompound 68-3 was dissolved in NHP24-3 (39.2 g, 83 mmol) was dissolved in saturated methanolic ammonia, and the resulting solution was stirred at R.T. for 15 hours. The solvent was removed, and the residue was purified on a silica gel column (DCM/MeOH=50:1 to 20:1) to give P24-4 (21.0 g, 95.8percent).j0298j Compound P24-3 (39.2 g, 83 mmol) was dissolved in saturated methanolic ammonia, and the resulting solution was stirred at R.T. for 15 hours. The solvent was removed, and the residue was purified on a silica gel column (DCM/MeOH = 50:1 to 20:1) to give P24-4 (21.0 g, 95.8percent).Compound 68-3 was dissolved in NH3/MeOH (600mL) and stirred overnight. The solvent was concentrated togive the residue, which was purified by silica gel columnchromatography (5percent MeOH in DCM) to give 68-4 (12 g, 99percent) as a white solid.
A metabolite of Gemcitabine (G305000) in human plasma.
Computed Properties
Molecular Weight:264.18
XLogP3:-1.3
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:2
Exact Mass:264.05577775
Monoisotopic Mass:264.05577775
Topological Polar Surface Area:99.1
Heavy Atom Count:18
Complexity:414
Defined Atom Stereocenter Count:3
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of 2',2'-DIFLUORO-2'-DEOXYURIDINE
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food AdditivesInquiryCAS No.: 114248-23-6Content: 99.00%
Learn More Other Chemicals
-
5'-deoxy-5'-thioinosine 5'-monophosphate
21959-63-7
-
1-(2-Deoxy-β-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone
22003-30-1
-
5'-azacytidine5'-monophosphate
2226-72-4
-
Decarboxylated AdoMet Formula
22365-13-5
-
2′-Deoxy-6-thioinosine Formula
2239-64-7
-
Quercetin 3-glucuronide Formula
22688-79-5
-
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(methylamino)pyrimidin-2-one Structure
22882-02-6
-
Sucrose Structure
57-50-1
-
What is C18Dihydroceramide
2304-80-5
-
What is [5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl adamantane-1-carboxylate
23113-01-1